Report Store | Pharma intelligence
  • My Account
    • 0Shopping Cart
  • $0.00
  • Disease analysis
    • Anemias
    • Bacterial infections
    • Bleeding disorders
    • Brain Cancer
    • Breast and gynecological cancer
    • Cardiovascular and Metabolic
    • Central Nervous System
    • Cerebrovascular diseases
    • Dermatology
    • Diabetes and diabetic complications
    • Gastroenterology
    • Gastrointestinal cancer
    • Head and Neck Cancer
    • Hypertension
    • Immunology and Inflammation
    • Infectious Diseases
    • Ischemic heart disease
    • Leukemia
    • Lung Cancer
    • Lymphoma
    • Oncology overview
    • Market Spotlight
    • Mens Health
    • Neurology
    • Oncology
    • Ophthalmology
    • Other Hematological Cancers
    • Other metabolic diseases
    • Other Solid Cancers
    • Pain
    • Psychiatry
    • Respiratory
    • Rheumatology
    • Skin cancer
    • Thrombosis
    • Urological cancer
    • Vaccines
    • Viral infections
    • Women’s Health
  • Strategy analysis
    • Bleeding disorders
    • Breast and gynecological cancer
    • Cardiovascular and Metabolic
    • Central Nervous System
    • Commercial Strategy
    • Dealmaking and R&D
    • Head and Neck Cancer
    • Hot Topics
    • Infectious Diseases
    • KOL Insight
    • Leukemia
    • Lung Cancer
    • Manufacturing
    • Market Access
    • Neurology
    • Oncology
    • Outsourcing
    • Pricing & Reimbursement
    • R&D
    • Regulatory & Therapeutic Area
    • Trends
    • Urological cancer
  • Company analysis
    • Big Pharma
    • Emerging Pharma
    • Hot Topics
    • Japan Pharma
    • M&A Analysis
    • Mid Pharma
  • Drug analysis
    • A
    • B-C
    • D-F
    • G-L
    • M-O
    • P-R
    • S-T
    • U-Z
  • MedTech analysis
    • Allergy
    • Autoimmune / Immunology
    • Cardiovascular
    • Dermatology
    • Endocrine
    • ENT / Dental
    • Gastroenterology
    • Hearing
    • Hematology
    • Infectious Diseases
    • Metabolic
    • Neurology
    • Obstetrics / Gynecology
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Osteoporosis
    • Psychiatry
    • Renal
    • Respiratory
    • Rheumatology
    • Urology
  • Opinion & analysis
    • Business Development
    • Business Management
    • Clinical Trials
    • Digital Health
    • Cybersecurity
    • Compliance & Risk
    • Digital patient management
    • Digital policy & regulation
    • Finance & Pricing
    • Healthcare Innovation
    • ICT and Health
    • Leadership
    • Legislation Regulation & Policy
    • Market Access
    • Market Intelligence
    • Medical
    • Pharmaceutical Device
    • Pharmaceutical Research
    • Strategy & Innovation
    • Tech companies & Data
    • Tech & Pharma
  • Blogs
  • Search
  • Menu
You are here: Home > MedTech analysis

MedTech analysis


  • Sort by Average rating
    • Default
    • Custom
    • Name
    • Price
    • Date
    • Popularity (sales)
    • Average rating
    • Relevance
    • Random
    • Product ID
  • Display 15 Products per page
    • 15 Products per page
    • 30 Products per page
    • 45 Products per page
  • Diagnostic and Guided Interventional Cardiology Products Market

    $4,750.00

    This comprehensive medical market and technology report provides an overview and in-depth market analysis of diagnostic and guided interventional cardiology devices (specifically, transcatheter angiography, guidewire-based intravascular stenosis assessment, intracardiac echocardiography (ICE), intravascular ultrasound (IVUS), optical coherence tomography (OCT), and robotic-assisted surgical systems) used in the diagnosis of cardiovascular diseases (CVDs) and guidance of minimally invasive therapies.

    July 31, 2017
    Find out more
  • Minimally Invasive Weight Loss (Bariatric) Devices Market

    $4,750.00

    The minimally invasive weight loss devices market (which includes laparoscopic adjustable gastric banding systems, intragastric balloon systems and implantable neuroregulators/gastric stimulation devices) was valued at more than $137m in 2016 and is expected to grow at a double-digit rate over the next 5 years. The overall market will be driven by highly favorable demographics, low penetration, strong demand for safe and effective nonsurgical weight loss therapies (filling an underserved market between weight loss drugs and drastic bariatric surgery) and increased adoption of novel, proprietary next-generation implantable weight loss technologies–particularly new/improved capsule-based intragastric balloon systems.

    July 28, 2017
    Find out more
  • Inhalation Drug Delivery Devices Market

    $4,750.00

    The combined prevalence of asthma and COPD in the countries covered by this report (US, Japan, and five major EU markets of France, Germany, Italy, Spain, and the UK) is 109.3 million. The combined market for inhalation drug delivery devices totaled nearly $11.7bn in 2016, and is expected to climb at a rate of 1.2% over the forecast period. Generic erosion will be a key factor in limiting growth in the overall market; however, increasing disease prevalence and the introduction of novel products such as triple combination therapies will offset declines. The US accounts for nearly two-thirds of the overall inhalation drug delivery devices market, and is expected to experience the most growth over the forecast period as its population increases and ages.

    July 19, 2017
    Find out more
  • Heart Valve Repair and Replacement Devices Market

    $4,750.00

    The global market for heart valve repair and replacement devices is being driven by the increasing burden of heart valve disease, which left untreated can lead to severe and life-threatening cardiovascular diseases.  This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the worldwide heart valve repair and replacement devices market, which includes percutaneous balloon valvuloplasty, heart valve surgery, transcatheter aortic valve replacement (TAVR), and transcatheter mitral valve regurgitation therapy (TMVrep). Global heart valve repair and replacement device sales are projected to expand at a compound annual growth rate (CAGR) of 10.9% during 2016-21, increasing from approximately $4,834.7m in 2016 to an estimated $8,094.4m in 2021. Countries/regions covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of the World segment (which combines estimated sales data for all other countries).

    July 1, 2017
    Find out more
  • General and Pelvic Endoscopic Surgery Devices Market

    $4,750.00

    This report provides an in-depth analysis of the global market for medical devices used in endoscopic general and pelvic surgeries.

    Medical devices covered in this report include:

    >  access devices
    >  access site closure devices
    > ancillary devices
    > endoscopes
    > hand instruments
    > insufflation products.

    This report provides the following useful information:

    > medical device product portfolios offered by leading manufacturers
    > procedure volumes for endoscopic general and pelvic surgeries
    > top-selling products, as well as emerging new products
    > in-depth market and competitive analysis

    June 12, 2017
    Find out more
  • Pain Management Devices Market

    Pain Management Devices Market

    $4,750.00

    This comprehensive medical market and technology report provides an overview of the medical devices (eg, electrical stimulators and analgesia infusion pumps) used in the management of chronic pain, and includes an in-depth market analysis. This global report covers the US, European, and Rest of World (RoW) markets.

    The report provides the following useful information:

    • pain management overview
    • key statistics on pain prevalence in major world regions
    • medical device product portfolios offered by leading manufacturers
    • top selling products, as well as emerging products under development
    • in-depth market and competitive analyses

    Medical devices covered in this report include:

    • electrical nerve stimulators (transcutaneous electrical nerve stimulators [TENS] and neurostimulation products including spinal cord stimulators [SCSs], discussed in Chapter 2)
    • analgesia infusion pumps and accessories (implantable analgesia infusion pumps and external analgesia infusion pumps, discussed in Chapter 3)
    June 1, 2017
    Find out more
  • Global Market for Arthroscopy and Sports Medicine Devices

    $4,750.00

    This report provides an analysis and sales forecast for the global market for arthroscopy and sports medicine devices.

    March 30, 2017
    Find out more
  • Global Diabetes Management Devices Market

    Global Diabetes Management Devices Market

    $4,750.00

    The global market for diabetes management devices—valued at more than $9bn in 2015—is a substantial, highly competitive market driven by highly sophisticated, evolving technology, particularly in the insulin pump/artificial pancreas and CGM area.

    March 30, 2017
    Find out more
  • PD-1/L1 Immunotherapies: Historical Sales and Market Trend Analysis Report

    $7,500.00

    Bristol-Myers Squibb’s (BMS) Opdivo (nivolumab) has outpaced Merck’s Keytruda (pembrolizumab) primarily
    in non-small cell lung cancer (NSCLC) because of its early approval in squamous NSCLC, updated National
    Comprehensive Cancer Network (NCCN) guidelines in 2015,

    December 22, 2016
    Find out more
  • Current and Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Therapies

    $4,750.00

    Approximately 16.3 million adults in the United States (U.S.) suffer from coronaryheart disease (CHD), a type of cardiovascular disease that is associated with areduction in blood flow through the vasculature of the heart (ischemic heart disease).

    March 1, 2013
    Find out more
  • United Kingdom, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure

    $1,995.00

    This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in the United Kingdom (U.K.); incidence and prevalence figures are compared with those of the Benelux countries

    December 3, 2012
    Find out more
  • US Neurointerventional Devices Market, September 2016

    $4,750.00

    Neurointerventional radiology/surgery, or neurovascular intervention, is a relatively new medical specialty employing minimally invasive endovascular techniques to treat vascular diseases of the brain.

    September 21, 2016
    Find out more
  • Spain, Neurological Market Opportunities: Disease Incidence and Prevalence, And Surgical Procedure Volumes

    $1,995.00

    This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in Spain

    December 3, 2012
    Find out more
  • Spain, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

    $1,995.00

    This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and procedures in Spain; incidence and prevalence figures are compared with those of the Benelux countries

    November 1, 2012
    Find out more
  • Italy, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

    $1,995.00

    This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in Italy; incidence and prevalence figures are compared with those of the Benelux countries

    December 3, 2012
    Find out more
Page 9 of 13
Page 9 of 13«‹7891011›»
  • Home
  • Terms and Conditions
  • Refund policy
  • Privacy Policy
  • Cookie Policy
  • Contact Us
  • About Us
  • Discounts
  • Market Spotlight – Reports
  • twitter
  • linkedin
  • Sitemap
Copyright © 2022 Pharma Intelligence UK Limited Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London, SW1P 1WG. Pharma Intelligence UK Limited is part of the Pharma Intelligence Group.

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence
This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Call Back
Scroll to top